Whole-process Quality Improvement of Endovascular Treatment Basd on an AI-aided Clinical Feedback System

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05874596
Collaborator
(none)
1,221
1
2
15
81.1

Study Details

Study Description

Brief Summary

A clustered randomized control trial to evaluate whether multi-aspect intervention based on an AI-aided clinical feedback system could improve the quality of EVT and functional outcome of patients.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: AI-aided clinical feedback system coupled with multi-aspect intervention basd on Behaviour Change Wheel model
N/A

Detailed Description

Endovascular treatment (EVT) is the standard treatment for acute ischemic stroke (AIS) caused by large vessel occlusion (LVO) according to current guidelines. However, while a rapidly-growing number of stroke centers become capable of performing EVT, the general quality of EVT remains unsatisfied, resulting in a considerable proportion of patients who could not reach functional independence. Our pre-established artificial intelligence (AI)-aided clinical feedback system could dynamically record and report key timepoints of EVT in-hospital process. Combined with multi-aspect intervention via remote/on-site surveillance and education, this may be a potential solution for quality improvement of EVT. Therefore, the aim of the study is to evaluate whether an AI-aided clinical feedback system coupled with multi-aspect intervention could improve the quality of EVT. Twenty hospitals with annual EVT cases > 30 will be 1:1 randomized into intervention group and control group. The intervention group will receive AI-based clinical feedback system coupled with multi-aspect intervention, including remote/on-site surveillance and education regarding in-hospital workflow and surgical procedures of EVT. The control group only deploys AI-aided clinical feedback system. The primary outcome is the ratio of good functional outcome (mRS > 2) at 3 month.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1221 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Whole-process Quality Improvement of Patients With Acute Ischemic Stroke Undergoing Endovascular Treatment Based on an Artificial Intelligence-aided Clinical Feedback System
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

AI-aided clinical feedback system coupled with multi-aspect intervention based on the Behaviour Change Wheel model

Behavioral: AI-aided clinical feedback system coupled with multi-aspect intervention basd on Behaviour Change Wheel model
Interventions are developed on a psychological model, the Behaviour Change Wheel (BCW) .The fundamental of BCW consists of three essential elements: capability, motivation, and opportunity. Improving individual's capability, providing motivation, and increasing opportunities are goals of behaviour change intervention. To achieve the goals, 9 intervention components have been proposed in the BCW framework, and 6 components will be used in current study.

No Intervention: Control

AI-aided clinical feedback system only

Outcome Measures

Primary Outcome Measures

  1. Ratio of favorable functional outcome at 3 month [3 months]

    Ratio of patients with mRS > 2 at 3-month follow up

Secondary Outcome Measures

  1. Ratio of good functional outcome at 3 month [3 months]

    Ratio of patients with mRS > 1 at 3-month follow up

  2. mRS score at 3 month [3 months]

    mRS score at 3-month follow up

  3. Mortality at 3 month [3 months]

    Mortality at 3-month follow up

  4. Ratio of hemorrhagic transformation at 24 hour [24 hours]

    Ratio of hemorrhagic transformation at 24 hour after EVT

  5. Ratio of symptomatic intracranial hemorrhage at 24 hour [24 hours]

    Ratio of symptomatic intracranial hemorrhage at 24 hour after EVT

  6. Door to groin puncture time [24 hours]

    Time interval between admission and groin puncture

  7. Ratio of door to groin puncture time < 90 min [24 hours]

    Time interval between admission and groin puncture <90 min

  8. Ratio of door to groin puncture time < 60 min [24 hours]

    Time interval between admission and groin puncture <60 min

  9. Procedural duration [24 hours]

    Time interval between groin puncture and last time of digital subtraction angiography

  10. Ratio of successful reperfusion [24 hours]

    Ratio of patients achieving modified thrombolysis in cerebral infarction (mTICI) 2b or 3

Other Outcome Measures

  1. Ratio of favorable functional outcome at 3 month in patients within 6 hours of stroke onset [3 months]

    Ratio of mRS > 2 at 3 month follow-up in patients within 6 hours of stroke onset

  2. Door to groin puncture time in patients within 6 hours of stroke onset [24 hours]

    Time interval between admission and groin puncture in patients within 6 hours of stroke onset

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age > 18

  • AIS patients receiving EVT within 24 hours of stroke onset

  • Written informed consent is obtained

Exclusion Criteria:
  • Patients refuse to participate in this study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou China

Sponsors and Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

Investigators

  • Principal Investigator: Zexin Chen, Ethics committee the second affiliated hospital, school of medicine, Zhejiang University, China

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Second Affiliated Hospital, School of Medicine, Zhejiang University
ClinicalTrials.gov Identifier:
NCT05874596
Other Study ID Numbers:
  • OPTIMAL
First Posted:
May 25, 2023
Last Update Posted:
May 25, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 25, 2023